Cell type-dependent control of NF-Y activity by TGF-beta

C Alabert1, L Rogers, L Kahn

  • 1Institut de Génétique Moléculaire de Montpellier, CNRS-UMR5535-IFR122, Montpellier, France.

Oncogene
|January 26, 2006
PubMed

Insights

Transforming growth factor beta (TGF-beta) activates the ERK cascade to move NF-YA into the nucleus, regulating gene expression. Cell type differences in MAPK pathway activation affect NF-YA

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor beta (TGF-beta) is a cytokine regulating cell growth and differentiation.
  • TGF-beta signaling involves Smad pathways and MAPK cascades.
  • The transcription factor NF-Y plays a role in cellular processes.

Purpose of the Study:

  • To investigate the mechanism of TGF-beta-induced NF-Y activation.
  • To determine the role of MAPK pathways in TGF-beta-mediated NF-YA nuclear translocation.
  • To explore cell type-specific differences in TGF-beta signaling.

Main Methods:

  • Treatment of NIH3T3 fibroblasts and MDCK cells with TGF-beta.
  • Analysis of NF-YA nuclear translocation.
  • Assessment of MAPK pathway activation (ERK, p38).
  • Chromatin immunoprecipitation to measure NF-Y binding.

Main Results:

  • TGF-beta induces NF-YA nuclear translocation via ERK cascade activation.
  • NF-Y binding to chromatin and cyclin A2 gene transcription are increased by TGF-beta.
  • Cell type-specific differences in p38 and ERK activation kinetics were observed.
  • NIH3T3 fibroblasts showed delayed NF-YA nuclear accumulation compared to MDCK cells.

Conclusions:

  • TGF-beta1-induced NF-Y activation involves ERK1/2.
  • MAPK pathway interplay contributes to TGF-beta signaling.
  • Cell-specific kinetics of NF-YA relocalization suggest finely tuned transcriptional regulation.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...